The incidence and relative risk of adverse events in patients treated with bisphosphonate therapy for breast cancer: a systematic review and meta-analysis

BACKGROUND: Adjuvant bisphosphonates reduce the rate of breast cancer recurrence in the bone and improve breast cancer survival. However, the risk of adverse events associated with bisphosphonate therapy for breast cancer remains poorly defined. METHODS: A literature search was conducted using the P...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Yan-Li, Xiang, Zi-Jian, Yang, Jing-Hua, Wang, Wen-Jie, Xiang, Ruo-Lan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Meta-Analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6558551/
https://www.ncbi.nlm.nih.gov/pubmed/31217825
http://dx.doi.org/10.1177/1758835919855235

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6558551/
https://www.ncbi.nlm.nih.gov/pubmed/31217825
http://dx.doi.org/10.1177/1758835919855235

Ejemplares similares